PDLIM2 and triple-negative breast carcinoma: PDLIM2 exhibits a dual role in cancer progression: it functions as a tumor suppressor in hormone-sensitive breast cancers and other malignancies, while paradoxically displaying elevated expression and pro-metastatic activity in triple-negative breast cancer (TNBC) and advanced metastatic tumors.